4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with Heart Failure in 2 studies
4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone: Inhibitor of phosphodiesterases.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mathew, R | 1 |
| Wang, J | 1 |
| Gewitz, MH | 1 |
| Hintze, TH | 1 |
| Wolin, MS | 1 |
| Matsumori, A | 1 |
| Ono, K | 1 |
| Sato, Y | 1 |
| Shioi, T | 1 |
| Nose, Y | 1 |
| Sasayama, S | 1 |
2 other studies available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and Heart Failure
| Article | Year |
|---|---|
Congestive heart failure alters receptor-dependent cAMP-mediated relaxation of canine pulmonary arteries.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Colforsin; Cyclic AMP; Cyclic GMP; Dogs; He | 1993 |
Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzy | 1996 |